News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Allergic Airway Inflammation and Airway Hyperreactivity is Mediated by IL17 Producing gamma/delta T Cells
Area: Inflammation
While the exact mechanisms are unknown, gamma/delta T cells are postulated to exert a regulatory influence during acute allergic airway disease. Allergic airway disease has been attributed to IL17 producing Th17 cells. A recently published study in Respiratory and Critical Care Medicine has found that gamma/delta T cells represent the main source of IL17 in the allergic lung. The study utilized a T-cell receptor antibody available at antibodies-online.
Gamma/delta T cells represent a small subset of T cells that possess a distinct T cell receptor (TCR) on their surface. They are also distinct in that they apparently do not require antigen processing and MHC presentation of peptide epitopes. Nevertheless, some gamma/delta T cells recognize MHC class IB molecules. This recent publication identifies these IL17 producing gamma/delta T cells as key regulators of allergic response in vivo.
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

